ArticleThe oncologist2023

Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study.

Hiroya Taniguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.